Serial 98293768
Live / Applied — Third extension granted (statement of use) (as of 09 Mar 2026)
What this means for you
Not registered yet, but its 01 Dec 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98293768
- Mark type
- Design / logo
- Filed
- 01 Dec 2023
- Published for opposition
- 06 Aug 2024
- Attorney of record
- Catherine E. Maxson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and biopharmaceutical products for the prevention and treatment of cancer; pharmaceutical and biopharmaceutical products for immunotherapy; chemical, biochemical, biologic and cell-based preparations for treatment of cancer; biologic and cell-based preparations for immunotherapy; pharmaceutical and biopharmaceutical substances for use in immunotherapy
Owner
- BrainChild Bio, Inc., Seattle, WA, US
- BrainChild Bio, Inc., Seattle, WA, US
Prosecution history
- 10 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Mar 2026 — SOU EXTENSION 3 GRANTED
- 09 Mar 2026 — SOU EXTENSION 3 FILED
- 09 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 10 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Sept 2025 — SOU EXTENSION 2 GRANTED
- 09 Sept 2025 — SOU EXTENSION 2 FILED
- 09 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Feb 2025 — SOU EXTENSION 1 GRANTED
- 25 Feb 2025 — SOU EXTENSION 1 FILED
- 25 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Aug 2024 — PUBLISHED FOR OPPOSITION